Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XJT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,750
Award facts
- Contract value 100% obligated
- $48,749.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 on May 29, 2025, for the supply of Stelara 90 mg/mL syringes. The contract, which carries an ultimate completion date of June 20, 2025, was issued without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Stelara, a biologic medication used to treat autoimmune conditions including psoriasis, rheumatoid arthritis, and ulcerative colitis, represents one of numerous specialty pharmaceutical products within DMS Pharmaceutical Group's extensive portfolio delivered to federal healthcare systems. The contractor's track record demonstrates consistent success in securing delivery orders covering branded and generic prescription drugs, biologics, oncology treatments, and medical consumables. Performance will be executed in Park Ridge, Illinois, with the delivery order supporting the Department of Defense's pharmaceutical supply requirements across military medical facilities.
Quick answers
Who was awarded contract SPE2DX25F6XJT?
SPE2DX25F6XJT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 29, 2025.
How much is contract SPE2DX25F6XJT worth?
The government has obligated $48,750 on SPE2DX25F6XJT.
Is contract SPE2DX25F6XJT an order under another contract?
Yes. SPE2DX25F6XJT is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XJT competed?
The extent of competition for SPE2DX25F6XJT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award